Iodine
In clinical developmentAlso known as Absorbine Veterinary Liniment, Barrier-Dyne, BovaPro, Bovadine+29 more
Absorbine Veterinary Liniment, Barrier-Dyne, BovaPro, Bovadine, ChoreMate One-Shot, Dairyland Brand Controlled Iodine Teat Dip, Defend II, Della Soft, Dermafive, EDX-1000, EDX-502, Eco-Gard, Eco-Plus, I2, Io-Blend, Io-Shield, Iodine Topical, Iodoshield, Jod, Lugols Strong Iodine, Optima Plus, Quarter Mate, QuarterMate Concentrate, Teat-Glo, Triumph, UdderBlend, Udderdine, West Dip, diiodine, iodo, jodum, molecular iodine, Iodip.
Recent clinical, regulatory, research and industry developments relating to this drug.
Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
Thyroid-Gut-Axis: How Does the Microbiota Influence Thyroid Function?
Reducing Microbial Levels in High Caries Risk Adults
Nutrition and brain development in early life.
Clinical Research Study Efficacy of a Prototype Oral Rinse
Effect of Dietary Iodine Supplementation on the Proliferation of Breast Cancer
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Reducing Microbial Levels in High Caries Risk Adults
Clinical Research Study Efficacy of a Prototype Oral Rinse
Recent completions
Trials that read out recently, adding to the completed evidence base.
Reducing Microbial Levels in High Caries Risk Adults
Clinical Research Study Efficacy of a Prototype Oral Rinse
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes6
Journals, researchers & institutions
- Journal of the National Comprehensive Cancer Network : JNCCN1
- Nutrients1
- Nutrition reviews1
- Amrein K1
- Ball D1
- Bernet V1
- Bischoff L1
- Blomain E1
- Busaidy NL1
- Campbell M1
- Cassara CJ1
- Abramson Cancer Center at the University of Pennsylvania.1
- Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.1
- City of Hope National Medical Center.1
- Dana-Farber/Brigham and Women's Cancer Center.1
- Duke Cancer Institute.1
- Fox Chase Cancer Center.1
Related diseases
Regulator-approved indications and conditions co-mentioned with this drug across the research literature. Number shows shared papers.
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 6 of the same disease areas as Iodine in the shared literature.
Studied across 6 of the same disease areas as Iodine in the shared literature.
Studied across 6 of the same disease areas as Iodine in the shared literature.
Studied across the same disease area as Iodine in the shared literature.
Studied across the same disease area as Iodine in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials